$MLAB
MESA LABORATORIES INC /CO/

2020 Q3 Form 10-Q Financial Statement

#000143774920022629 Filed on November 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2019 Q3
Revenue $31.86M $29.94M $25.54M
YoY Change 24.77% 13.9% 2.7%
Cost Of Revenue $10.58M $9.601M $9.950M
YoY Change 6.28% -5.4% -3.29%
Gross Profit $21.29M $20.34M $15.59M
YoY Change 36.56% 25.52% 6.92%
Gross Profit Margin 66.81% 67.93% 61.04%
Selling, General & Admin $14.40M $14.17M $9.977M
YoY Change 44.34% 45.7% 7.31%
% of Gross Profit 67.66% 69.69% 64.01%
Research & Development $2.414M $2.596M $915.0K
YoY Change 163.83% 154.76% 8.67%
% of Gross Profit 11.34% 12.76% 5.87%
Depreciation & Amortization $4.420M $3.908M $2.260M
YoY Change 95.58% 79.18% -7.0%
% of Gross Profit 20.77% 19.21% 14.5%
Operating Expenses $16.82M $16.77M $10.89M
YoY Change 54.38% 56.04% -18.95%
Operating Profit $4.470M $3.570M $4.694M
YoY Change -4.77% -33.79% 312.48%
Interest Expense $1.934M $1.919M $1.397M
YoY Change 38.44% 385.82%
% of Operating Profit 43.27% 53.75% 29.76%
Other Income/Expense, Net -$2.086M -$2.816M -$920.0K
YoY Change 126.74% 8700.0% -647.62%
Pretax Income $2.384M $754.0K $3.774M
YoY Change -36.83% -85.93% 188.97%
Income Tax -$295.0K -$463.0K $602.0K
% Of Pretax Income -12.37% -61.41% 15.95%
Net Earnings $2.679M $1.217M $3.170M
YoY Change -15.49% -73.88% 218.91%
Net Earnings / Revenue 8.41% 4.06% 12.41%
Basic Earnings Per Share $0.52 $0.27 $0.76
Diluted Earnings Per Share $0.51 $0.26 $0.73
COMMON SHARES
Basic Shares Outstanding 5.110M 4.528M 4.155M
Diluted Shares Outstanding 5.241M 4.669M 4.321M

Balance Sheet

Concept 2020 Q3 2020 Q2 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $241.9M $231.0M $245.4M
YoY Change -1.43% 3064.38% 4282.14%
Cash & Equivalents $241.9M $231.0M $245.4M
Short-Term Investments
Other Short-Term Assets $7.800M $8.000M $6.200M
YoY Change 25.81% 21.21% -3.13%
Inventory $11.84M $12.90M $6.848M
Prepaid Expenses
Receivables $18.56M $17.93M $12.23M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $280.1M $269.8M $270.7M
YoY Change 3.47% 697.53% 705.95%
LONG-TERM ASSETS
Property, Plant & Equipment $22.31M $21.80M $21.73M
YoY Change 2.66% -0.85% -6.47%
Goodwill $156.4M $153.9M $67.09M
YoY Change 133.08% 128.33% 3.08%
Intangibles $116.7M $117.5M $31.53M
YoY Change 270.17% 248.18% -17.6%
Long-Term Investments
YoY Change
Other Assets $1.977M $2.254M $1.173M
YoY Change 68.54% 65.61% 1073.0%
Total Long-Term Assets $308.8M $307.0M $121.7M
YoY Change 153.67% 143.93% -3.91%
TOTAL ASSETS
Total Short-Term Assets $280.1M $269.8M $270.7M
Total Long-Term Assets $308.8M $307.0M $121.7M
Total Assets $588.9M $576.7M $392.5M
YoY Change 50.06% 261.2% 144.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.852M $2.812M $2.339M
YoY Change -20.82% -10.16% 1.92%
Accrued Expenses $4.753M $5.944M $4.673M
YoY Change 1.71% 24.04% 27.5%
Deferred Revenue $6.790M $5.858M $3.980M
YoY Change 70.6% 43.37%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.53M $20.48M $16.74M
YoY Change 16.68% -3.98% -14.29%
LONG-TERM LIABILITIES
Long-Term Debt $142.9M $141.6M $137.7M
YoY Change 3.78% 708.59% 341.52%
Other Long-Term Liabilities $952.0K $1.190M $485.0K
YoY Change 96.29% 70.98% 264.66%
Total Long-Term Liabilities $952.0K $1.190M $485.0K
YoY Change 96.29% -93.46% -98.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.53M $20.48M $16.74M
Total Long-Term Liabilities $952.0K $1.190M $485.0K
Total Liabilities $196.5M $194.5M $163.3M
YoY Change 20.34% 378.78% 205.91%
SHAREHOLDERS EQUITY
Retained Earnings $74.72M $72.24M $79.64M
YoY Change -6.17% -6.51% 10.19%
Common Stock $309.9M $306.9M $152.0M
YoY Change 103.88% 607.1% 329.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $392.4M $382.2M $230.2M
YoY Change
Total Liabilities & Shareholders Equity $588.9M $576.7M $392.5M
YoY Change 50.06% 261.2% 144.85%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2019 Q3
OPERATING ACTIVITIES
Net Income $2.679M $1.217M $3.170M
YoY Change -15.49% -73.88% 218.91%
Depreciation, Depletion And Amortization $4.420M $3.908M $2.260M
YoY Change 95.58% 79.18% -7.0%
Cash From Operating Activities $10.54M $2.260M $6.430M
YoY Change 63.92% 212.15% 75.68%
INVESTING ACTIVITIES
Capital Expenditures -$490.0K $216.0K -$310.0K
YoY Change 58.06% -4.42% -43.64%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$490.0K -$216.0K -$320.0K
YoY Change 53.12% -92.23% -119.16%
FINANCING ACTIVITIES
Cash Dividend Paid $704.0K
YoY Change 12.82%
Common Stock Issuance & Retirement, Net $145.9M $85.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 210.0K $146.9M 232.2M
YoY Change -99.91% -16153.01% -3484.26%
NET CHANGE
Cash From Operating Activities 10.54M $2.260M 6.430M
Cash From Investing Activities -490.0K -$216.0K -320.0K
Cash From Financing Activities 210.0K $146.9M 232.2M
Net Change In Cash 10.26M $149.6M 238.3M
YoY Change -95.69% -5311.53% -15673.2%
FREE CASH FLOW
Cash From Operating Activities $10.54M $2.260M $6.430M
Capital Expenditures -$490.0K $216.0K -$310.0K
Free Cash Flow $11.03M $2.044M $6.740M
YoY Change 63.65% 310.44% 60.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5118653
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
168000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
159000 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14087000 USD
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12741000 USD
CY2020Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5117441
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5117441
CY2019Q3 mlab Payments Of Debt Conversion Costs
PaymentsOfDebtConversionCosts
8338000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
230246000 USD
CY2020Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3408000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5611000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8940000 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6790000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6814000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
527000 USD
CY2020Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
504000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4753000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6342000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
19533000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
26008000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
33090000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
32549000 USD
CY2020Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
142945000 USD
CY2020Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
140278000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
952000 USD
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4387140
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4387140
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
9315000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
382234000 USD
CY2020Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
392412000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1358000 USD
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 pure
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
241924000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81380000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18563000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21132000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
11837000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
14230000 USD
CY2020Q3 us-gaap Prepaid Taxes
PrepaidTaxes
3344000 USD
CY2020Q1 us-gaap Prepaid Taxes
PrepaidTaxes
1914000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4457000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4136000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
280125000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
122792000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22309000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22066000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11453000 USD
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11461000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1977000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2480000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
116703000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
119871000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
156365000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
141536000 USD
CY2020Q3 us-gaap Assets
Assets
588932000 USD
CY2020Q1 us-gaap Assets
Assets
420206000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1852000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4902000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-952000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2384000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
392412000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
1397000 USD
us-gaap Interest Expense
InterestExpense
3853000 USD
us-gaap Interest Expense
InterestExpense
1593000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-152000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
477000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1049000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
641000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2086000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-920000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
196520000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
200193000 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
309935000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
158023000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
74724000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
72359000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7753000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10369000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
220013000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
588932000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
420206000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31860000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25536000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61801000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51824000 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
10575000 USD
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
9950000 USD
us-gaap Cost Of Revenue
CostOfRevenue
20176000 USD
us-gaap Cost Of Revenue
CostOfRevenue
20034000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
21285000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
15586000 USD
us-gaap Gross Profit
GrossProfit
41625000 USD
us-gaap Gross Profit
GrossProfit
31790000 USD
CY2020Q3 us-gaap Selling Expense
SellingExpense
3786000 USD
CY2019Q3 us-gaap Selling Expense
SellingExpense
2274000 USD
us-gaap Selling Expense
SellingExpense
7861000 USD
us-gaap Selling Expense
SellingExpense
4482000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10615000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7703000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20714000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15223000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2414000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
915000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5010000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1934000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
16815000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
10892000 USD
us-gaap Operating Expenses
OperatingExpenses
33585000 USD
us-gaap Operating Expenses
OperatingExpenses
21639000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4470000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4694000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
8040000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
10151000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
1934000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3774000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3138000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9199000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-295000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
602000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-758000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1365000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2679000 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3172000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3896000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7834000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.94
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.86
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5110000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4155000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4821000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4029000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5241000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4321000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4958000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4205000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2679000 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3172000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3896000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7834000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5262000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-986000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
18122000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-865000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7941000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2186000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22018000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6969000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3896000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7834000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8333000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4444000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3276000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2050000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
2667000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
706000 USD
mlab Amortization Of Inventory Stepup Cost
AmortizationOfInventoryStepupCost
-436000 USD
mlab Amortization Of Inventory Stepup Cost
AmortizationOfInventoryStepupCost
0 USD
mlab Increase Decrease In Inventory Reserve
IncreaseDecreaseInInventoryReserve
-258000 USD
mlab Increase Decrease In Inventory Reserve
IncreaseDecreaseInInventoryReserve
-70000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-499000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-129000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3077000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-246000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
464000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-295000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1941000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2508000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1604000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-746000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4811000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5385000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-140000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
14000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12610000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7149000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
-0 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
2555000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
707000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
543000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-707000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3098000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
167070000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
145935000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
84995000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
-0 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
23000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
1522000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
1321000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
10000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
11000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2701000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3507000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
147104000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
231240000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1537000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-33000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
160544000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
235258000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
81380000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10185000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
241924000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
245443000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
220013000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
145935000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1654000 USD
CY2020Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
704000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1268000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
12860000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1217000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1047000 USD
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
818000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2008000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5262000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2679000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
111311000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2709000 USD
CY2019Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
624000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
868000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
121000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
11837000 USD
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4662000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
119047000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
798000 USD
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
84995000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
22735000 USD
CY2019Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
697000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1182000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-986000 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3172000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4 pure
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31860000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25536000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61801000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51824000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31860000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25536000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61801000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51824000 USD
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7217000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3353000 USD
mlab Contract With Customer Liability Increase During Period Net Of Revenue Recognized
ContractWithCustomerLiabilityIncreaseDuringPeriodNetOfRevenueRecognized
3272000 USD
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7136000 USD
CY2020Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
222806000 USD
CY2020Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
66735000 USD
CY2020Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
7263000 USD
CY2020Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
6757000 USD
CY2020Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
357000 USD
CY2020Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
329000 USD
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7099000 USD
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9768000 USD
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2882000 USD
CY2020Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2624000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
14230000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
174006000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
57303000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
116703000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
169123000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
49252000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
119871000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3512000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6866000 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1658000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3330000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
14635000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
14599000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
14581000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
14056000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
12471000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
141536000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
9164000 USD
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
5665000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
156365000 USD
CY2020Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1771000 USD
CY2020Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
4069000 USD
CY2020Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2146000 USD
CY2020Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2485000 USD
CY2020Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1504000 USD
CY2020Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
2228000 USD
CY2020Q3 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
190000 USD
CY2020Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
158000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5611000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8940000 USD
CY2020Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
1965000 USD
CY2020Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
3796000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
945000 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1095000 USD
CY2020Q3 us-gaap Interest Payable Current
InterestPayableCurrent
296000 USD
CY2020Q1 us-gaap Interest Payable Current
InterestPayableCurrent
296000 USD
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
494000 USD
CY2020Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
857000 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1053000 USD
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
298000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4753000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6342000 USD
CY2020Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
593000 USD
CY2019Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
316000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1186000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
316000 USD
CY2020Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1341000 USD
CY2019Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
707000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2667000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
707000 USD
CY2020Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1934000 USD
CY2019Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1023000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
3853000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
1023000 USD
CY2020Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
600000
CY2020Q2 mlab Sale Of Stock Underwriter Options Shares
SaleOfStockUnderwriterOptionsShares
90000
CY2020Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
225.00
CY2020Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
145935000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2008000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1182000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3276000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2050000 USD
CY2020Q3 mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-522000 USD
CY2019Q3 mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-368000 USD
mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-1447000 USD
mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-908000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
1486000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
814000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
1829000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
1142000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4958000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4205000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
286000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
107.72
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
36000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
226.72
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
10000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
112.27
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
36000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
83.69
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
276000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
126.30
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2679000 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3172000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3896000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7834000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5110000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4155000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4821000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4029000
CY2020Q3 mlab Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
119000
CY2019Q3 mlab Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
156000
mlab Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
125000
mlab Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
166000
CY2020Q3 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
12000
CY2019Q3 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
10000
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
12000
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
10000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5241000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4321000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.94
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.86
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
692000
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
378000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
676000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.124 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.242 pure
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.160 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.148 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
630000 USD
CY2020Q3 us-gaap Tax Cuts And Jobs Act Of2017 Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit
-630000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
6435000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31860000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
21285000 USD
CY2020Q3 mlab General And Administrative Research And Development Other Expense
GeneralAndAdministrativeResearchAndDevelopmentOtherExpense
-18901000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2384000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25536000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
15586000 USD
CY2019Q3 mlab General And Administrative Research And Development Other Expense
GeneralAndAdministrativeResearchAndDevelopmentOtherExpense
-11812000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3774000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61801000 USD
us-gaap Gross Profit
GrossProfit
41625000 USD
mlab General And Administrative Research And Development Other Expense
GeneralAndAdministrativeResearchAndDevelopmentOtherExpense
-38487000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3138000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51824000 USD
us-gaap Gross Profit
GrossProfit
31790000 USD
mlab General And Administrative Research And Development Other Expense
GeneralAndAdministrativeResearchAndDevelopmentOtherExpense
-22591000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9199000 USD
CY2020Q3 us-gaap Assets
Assets
588932000 USD
CY2020Q1 us-gaap Assets
Assets
420206000 USD

Files In Submission

Name View Source Status
0001437749-20-022629-index-headers.html Edgar Link pending
0001437749-20-022629-index.html Edgar Link pending
0001437749-20-022629.txt Edgar Link pending
0001437749-20-022629-xbrl.zip Edgar Link pending
ex_201894.htm Edgar Link pending
ex_201895.htm Edgar Link pending
ex_201896.htm Edgar Link pending
ex_201897.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mlab-20200930.xsd Edgar Link pending
mlab-20200930_cal.xml Edgar Link unprocessable
mlab-20200930_def.xml Edgar Link unprocessable
mlab-20200930_lab.xml Edgar Link unprocessable
mlab-20200930_pre.xml Edgar Link unprocessable
mlab20200930_10q.htm Edgar Link pending
mlab20200930_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending